ATE229324T1 - Konservierungsmittel für lokale pharmazeutische zubereitungen enthaltend eine fettsäure/aminosäure enthaltende seife - Google Patents

Konservierungsmittel für lokale pharmazeutische zubereitungen enthaltend eine fettsäure/aminosäure enthaltende seife

Info

Publication number
ATE229324T1
ATE229324T1 AT99951564T AT99951564T ATE229324T1 AT E229324 T1 ATE229324 T1 AT E229324T1 AT 99951564 T AT99951564 T AT 99951564T AT 99951564 T AT99951564 T AT 99951564T AT E229324 T1 ATE229324 T1 AT E229324T1
Authority
AT
Austria
Prior art keywords
preservative
amino acid
pharmaceutical preparations
fatty acid
soap
Prior art date
Application number
AT99951564T
Other languages
English (en)
Inventor
Ernesto J Castillo
Steven Howard Gerson
Wesley Wehsin Han
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Application granted granted Critical
Publication of ATE229324T1 publication Critical patent/ATE229324T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
AT99951564T 1998-10-27 1999-09-21 Konservierungsmittel für lokale pharmazeutische zubereitungen enthaltend eine fettsäure/aminosäure enthaltende seife ATE229324T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10581998P 1998-10-27 1998-10-27
PCT/US1999/022003 WO2000024375A1 (en) 1998-10-27 1999-09-21 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap

Publications (1)

Publication Number Publication Date
ATE229324T1 true ATE229324T1 (de) 2002-12-15

Family

ID=22307952

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99951564T ATE229324T1 (de) 1998-10-27 1999-09-21 Konservierungsmittel für lokale pharmazeutische zubereitungen enthaltend eine fettsäure/aminosäure enthaltende seife

Country Status (13)

Country Link
US (1) US6284749B1 (de)
EP (1) EP1124535B1 (de)
JP (1) JP2002528404A (de)
AT (1) ATE229324T1 (de)
AU (1) AU753462B2 (de)
BR (1) BR9914799A (de)
CA (1) CA2340225A1 (de)
DE (1) DE69904498T2 (de)
DK (1) DK1124535T3 (de)
ES (1) ES2187203T3 (de)
PT (1) PT1124535E (de)
TW (1) TW581688B (de)
WO (1) WO2000024375A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444710B1 (en) 1998-10-27 2002-09-03 Alcon Manufacturing, Ltd. Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
BR0014117A (pt) * 1999-09-21 2002-05-14 Alcon Lab Inc Uso de sabÈes de acido graxo/aminoácido para aumentar a eficácia antimicrobiana de composições farmacêutica tópicas
US6716970B2 (en) 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
AU2001254819A1 (en) * 2001-04-28 2002-11-11 Lamirsa (Laboratorios Miret, S.A.) Antimicrobial composition comprising potassium sorbate and lae
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
US6806213B2 (en) * 2001-12-20 2004-10-19 Kimberly-Clark Worldwide, Inc. Disposable wash cloth and method of using
DE60228615D1 (de) * 2001-12-21 2008-10-09 3M Innovative Properties Co Medizinische aerosolzusammensetzungen mit einer eine amid- und/oder estergruppe enthaltenden exzipientenverbindung
AU2002361850A1 (en) * 2001-12-21 2003-07-30 3M Innovative Properties Company Medicinal aerosol formulations comprising ion pair complexes
DE60231428D1 (de) * 2001-12-21 2009-04-16 3M Innovative Properties Co Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff
JP4725699B2 (ja) * 2002-04-08 2011-07-13 ライオン株式会社 眼科用組成物及び眼科用組成物配合用防腐剤
JP2010031052A (ja) * 2002-04-08 2010-02-12 Lion Corp 眼科用組成物、及び眼科製剤用防腐組成物
WO2003086332A1 (en) * 2002-04-11 2003-10-23 Dvm Pharmaceuticals, Inc. Antimicrobial wash and carrier solutions, and uses thereof
US20040266776A1 (en) 2003-06-25 2004-12-30 Gil Daniel W. Methods of preventing and reducing the severity of stress-associated conditions
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formulations of palonosetron
TWI355936B (en) * 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
US7125967B2 (en) * 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
US20060167072A1 (en) * 2004-01-30 2006-07-27 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
ITCR20040004A1 (it) * 2004-02-05 2004-05-05 I C F Ind Chimica Fine S R L Detergente auricolare per animali, in particolare per cani e gatti
EP2219602A1 (de) 2007-11-15 2010-08-25 Amgen, Inc Wässrige formulierung von mit antioxidantien stabilisiertem erythropoese-stimulierendem protein zur parenteralen verabreichung
EP2278953B1 (de) * 2008-05-28 2016-05-04 Alcon Research, Ltd Selbsterhaltende emulsionen
DE102009034771B4 (de) 2009-07-25 2011-09-01 Martin Schmitt Hautschutzmittel
WO2011017909A1 (zh) * 2009-08-12 2011-02-17 鲁南贝特制药有限公司 盐酸西替利嗪的药物溶液
CN106398905A (zh) * 2016-09-06 2017-02-15 佛山市芊茹化妆品有限公司 2‑氨基‑2‑甲基丙烷的羟基取代物在氨基酸透明皂中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275503A (en) 1964-08-26 1966-09-27 Patterson Co C Method for the protection of loci susceptible to the growth of undesired microorganisms
US4380637A (en) 1978-11-30 1983-04-19 Johnson & Johnson/Mona Industries, Inc. Imidazoline phosphobetaines
US4485029A (en) 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
DE3670569D1 (de) 1985-03-01 1990-05-31 Procter & Gamble Milder reinigungsschaum.
CA1302280C (en) 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
US5000868A (en) 1987-04-03 1991-03-19 Wittpenn Jr John R Surfactant compositions
US5093126A (en) 1987-09-26 1992-03-03 Alcon Laboratories, Inc. Glaucoma formulations comprising an anionic, polysulfonic acid polymer having mucomimetic properties and a polystyrene sulfonic polymer
JPH0665058A (ja) * 1992-08-24 1994-03-08 Pola Chem Ind Inc 洗浄剤組成物
US5520920A (en) * 1992-08-28 1996-05-28 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
US5504113A (en) 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
US5536305A (en) 1994-06-08 1996-07-16 Yu; Bing Low leaching compositions for wood
DE69513170T2 (de) 1994-06-20 2000-03-09 Unilever N.V. Verbesserungen bezüglich antimikrobieller reinigungsmittel
AU3070395A (en) 1994-07-22 1996-02-22 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US5494937A (en) 1994-07-22 1996-02-27 Alcon Laboratories, Inc. Saline solution for treating contact lenses
US5641480A (en) 1994-12-08 1997-06-24 Lever Brothers Company, Division Of Conopco, Inc. Hair care compositions comprising heteroatom containing alkyl aldonamide compounds

Also Published As

Publication number Publication date
PT1124535E (pt) 2003-04-30
AU753462B2 (en) 2002-10-17
ES2187203T3 (es) 2003-05-16
US6284749B1 (en) 2001-09-04
AU6398199A (en) 2000-05-15
DK1124535T3 (da) 2003-01-06
CA2340225A1 (en) 2000-05-04
EP1124535B1 (de) 2002-12-11
JP2002528404A (ja) 2002-09-03
DE69904498T2 (de) 2003-04-24
TW581688B (en) 2004-04-01
BR9914799A (pt) 2001-07-10
DE69904498D1 (de) 2003-01-23
EP1124535A1 (de) 2001-08-22
WO2000024375A1 (en) 2000-05-04

Similar Documents

Publication Publication Date Title
ATE229324T1 (de) Konservierungsmittel für lokale pharmazeutische zubereitungen enthaltend eine fettsäure/aminosäure enthaltende seife
DE60130135D1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
DK0823940T3 (da) Vandige detergentsammensætninger, der indeholder chelateringsmidler, der forbliver uopløste under sure betingelser
BR9914813A (pt) Sistema conservante para composições farmacêuticas administráveis topicamente
EP0095615A3 (de) Präparat zum Konditionieren der Haut
BR9714310A (pt) Composição farmacêutica
MX21452A (es) Preparaciones farmaceuticas que se administran en forma topica.
FI960032L (fi) Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten
DK1187601T3 (da) Hidtil ukendt præparat og administrationsform som omfatter en syrelabil protonpumpeinhibitor
EP0783299A4 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
AU1446388A (en) Preparation of serine-n, n-diacetic acid and derivatives as complexing agents and detergents containing same
DE69521672D1 (de) Topisch verabreichbare zinkphthalocyaninhaltige Mittel
DE3761286D1 (de) Haarkosmetische mittel.
PE20011304A1 (es) Composicion farmaceutica que comprende una sal acida de amina simpaticomimetica soluble en agua y un denaturante y metodo para interferir fisicamente con la extraccion de una sal acida de una amina simpaticomimetica soluble en agua a partir de la mis
ES2179103T3 (es) Composicion detergente.
AU1446488A (en) 2-hydroxy-3-aminopropionic-n,n-diacetic acid and derivatives thereof, preparation thereof, and detergents containing same
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
FR2804319B1 (fr) Composition cosmetique amincissante comprenant en tant qu'agent actif un extrait de plante contenant de l'anp
BR9610930A (pt) Composição depilatória incluindo uma quantidade funcional de um agente tixoitrópico, e, uso da quantidade funcional de um agente tixotrópico.
ATE332728T1 (de) Photoempfindliche sonnenschutzmittel
IT1255076B (it) Microsfere biodegradabili ad uso farmaceutico e cosmetico
DE50000033D1 (de) Haarwaschmittel
BR0011864A (pt) Formulações farmacêuticas
MX21453A (es) Preparaciones farmaceuticas que se administran en forma topica.
MX9102021A (es) Composiciones detergentes o blanqueadoras granuladas que contienen blanqueador de midoperoxiacido y perfume.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1124535

Country of ref document: EP

REN Ceased due to non-payment of the annual fee